CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-22 | MOMTAZEE JAMES C Director | Grant or award · Stock Option (Right to Buy) | +5,277 | 5,277 | ||
| 2026-06-22 | MCCORMICK FRANK Director | Grant or award | +3,990 | 10,579 | ||
| 2026-06-22 | MCCORMICK FRANK Director | Grant or award · Stock Option (Right to Buy) | +5,277 | 5,277 | ||
| 2026-06-22 | Dachille Douglas A. Director | Grant or award | +3,990 | 10,579 | ||
| 2026-06-22 | Dachille Douglas A. Director | Grant or award · Stock Option (Right to Buy) | +5,277 | 5,277 | ||
| 2026-06-22 | Satvat Ali J. Director | Grant or award | +3,990 | 169,983 | ||
| 2026-06-22 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +5,277 | 5,277 | ||
| 2026-06-20 | HOMCY CHARLES J Director | Shares withheld for taxes | −788 | $66.27 | $52K | 915,886 |
| 2026-06-15 | Cook Jennifer E. Director | Option exercise 10b5-1 | +65,921 | $8.45 | $557K | 79,662 |
| 2026-06-15 | Cook Jennifer E. Director | Option exercise 10b5-1 | +17,167 | $16.75 | $288K | 96,829 |
| 2026-06-15 | Cook Jennifer E. Director | Sale 10b5-1 | −88,737 | $66.62 | $5.9M | 8,092 |
| 2026-06-15 | Cook Jennifer E. Director | Sale 10b5-1 | −1,503 | $67.14 | $101K | 6,589 |
| 2026-06-15 | Cook Jennifer E. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −65,921 | 39,000 | ||
| 2026-06-15 | Cook Jennifer E. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,167 | 34,334 | ||
| 2026-06-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −7,147 | $67.20 | $480K | 528,539 |
| 2026-06-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,437 | $67.88 | $573K | 520,102 |
| 2026-06-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −4,416 | $68.96 | $305K | 515,686 |
| 2026-06-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −7,148 | $67.20 | $480K | 4,331,299 |
| 2026-06-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,437 | $67.88 | $573K | 4,322,862 |
| 2026-06-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −4,415 | $68.96 | $304K | 4,318,447 |
Page 4 of 19 · 373 trades